Published on:

FDA Warns Consumers of Potentially Unsafe Drugs

Yesterday, the FDA listed nineteen types of drugs that it has flagged as potentially dangerous to consumers. From October to December 2008, the FDA’s Adverse Event Reporting System (AERS) has catalogued potential problems with each of the drugs. Of course, the FDA’s investigation is not complete; however, the goal is to notify consumers so that they can discuss their medications with their physician.

Miller & Zois has discussed some of these products already—see Reglan (polyethylene glycol oral laxative), Chantix (Varenicline) and Testosterone Gel. Other drugs on the list include:

 Apomorphine (Apokyn)
 Choriogonadotropin alfa (Ovidrel)
 Clomiphene citrate (Clomid)
 Clozapine orally disintegrating tablet (FazaClo)
 Darifenacin (Enablex) and Solifenacin (Vesicare)
 Drospirenone/ethinyl estradiol (Yasmin)
 Efavirenz (Sustiva)
 Fibrin sealant, human (Evicel)
 Hydrochlorothiazide
 Imiquimod cream (Aldara)
 Modafinil (Provigil) and Armodafinil (Nuvigil)
 Orlistat (Xenical, Alli)
 Raltegravir (Isentress)
 Selegiline (Emsam)
 Sumatriptan/naproxen (Treximet)
 Tolterodine tartrate (Detrol)

Of course, if you or a loved one take any of these medications, talk with your doctor to determine if the benefits outweigh the risks.